Works matching IS 09024441 AND DT 2020 AND VI 105 AND IP 2

Results: 15

R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 223, doi. 10.1111/ejh.13429

By:

Lacout, Carole;
Orvain, Corentin;
Seegers, Valérie;
De Vries, Manon;
Mercier, Mélanie;
Farhi, Jonathan;
Clavert, Aline;
Thepot, Sylvain;
Moles, Marie‐Pierre;
Ifrah, Norbert;
Hunault‐Berger, Mathilde;
Tanguy‐Schmidt, Aline

Publication type:

Article

Treatment of transfusion‐dependent congenital dyserythropoietic anemia Type I patients with pegylated interferon alpha‐2a.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 216, doi. 10.1111/ejh.13428

By:

Abu‐Quider, Abed;
Asleh, Mahdi;
Shalev, Hanna;
Fruchtman, Yariv;
Ben‐Harosh, Meriam;
Beck, Guy;
Kapelushnik, Josef

Publication type:

Article

Cost‐effectiveness of Anti‐CD19 chimeric antigen receptor T‐Cell therapy in pediatric relapsed/refractory B‐cell acute lymphoblastic leukemia. A societal view.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 203, doi. 10.1111/ejh.13427

By:

Thielen, Frederick W.;
Dongen‐Leunis, Annemieke;
Arons, Alexander M. M.;
Ladestein, Judith R.;
Hoogerbrugge, Peter M.;
Uyl‐de Groot, Carin A.

Publication type:

Article

Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real‐life outcomes of daratumumab treatment.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 196, doi. 10.1111/ejh.13426

By:

Afram, Garbriel;
Gran, Charlotte;
Borg Bruchfeld, Johanna;
Wagner, Arnika Kathleen;
Hussain, Alamdar;
Alici, Evren;
Nahi, Hareth

Publication type:

Article

Osteoclast stimulatory transmembrane protein (OC‐STAMP) is a promising molecular prognostic indicator for multiple myeloma.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 185, doi. 10.1111/ejh.13425

By:

Wang, Zi‐Long;
Liu, Yang;
Zhou, Ya‐Lan;
Li, Jin‐Lan;
Sun, Qiu‐Yu;
Wu, Li‐Xin;
Wen, Lei;
Lai, Yue‐Yun;
Liu, Yan‐Rong;
Chang, Ying‐Jun;
Shi, Hong‐Xia;
Liu, Kai‐Yan;
Huang, Xiao‐Jun;
Lu, Jin;
Ruan, Guo‐Rui

Publication type:

Article

Prevalence of pyruvate kinase deficiency: A systematic literature review.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 173, doi. 10.1111/ejh.13424

By:

Secrest, Matthew H.;
Storm, Mike;
Carrington, Courtney;
Casso, Deborah;
Gilroy, Keely;
Pladson, Leanne;
Boscoe, Audra N.

Publication type:

Article

Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 103, doi. 10.1111/ejh.13423

By:

Jeanpierre, Emmanuelle;
Pouplard, Claire;
Lasne, Dominique;
Le Cam Duchez, Véronique;
Eschwege, Valérie;
Flaujac, Claire;
Galinat, Hubert;
Harzallah, Ines;
Proulle, Valérie;
Smahi, Motalib;
Sobas, Frédéric;
Stepina, Nataliia;
Toulon, Pierre;
Voisin, Sophie;
Ternisien, Catherine;
Nougier, Christophe;
Gelas, Martine Alhenc;
Biron, Christine;
Blanc‐Jouvan, Florence;
Bourgerette, Evelyne

Publication type:

Article

DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 231, doi. 10.1111/ejh.13422

By:

Djebbari, Faouzi;
De Abrew, Kanchana;
Salhan, Beena;
Panitsas, Fotios;
Hossain, Md Imran;
Eyre, Toby A;
Willan, John;
Ramasamy, Karthik;
Basu, Supratik;
Jenner, Matthew;
Kothari, Jaimal

Publication type:

Article

BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 164, doi. 10.1111/ejh.13420

By:

Santoro, Cristina;
Fuh, Beng;
Le, Phu Quoc;
Maes, Philip;
Berrueco, Rubén;
Mingot‐Castellano, Eva Maria;
von Mackensen, Sylvia;
Solms, Alexander;
Wang, Michael

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2020, v. 105, n. 2, p. 101, doi. 10.1111/ejh.13258
Publication type:: Article

Food‐effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 148, doi. 10.1111/ejh.13418

By:

Boons, Christel C. L. M.;
Hartog, Yvonne M.;
Janssen, Jeroen J. W. M.;
Zandvliet, Anthe S.;
Vos, René M.;
Swart, Eleonora L.;
Hendrikse, N. Harry;
Hugtenburg, Jacqueline G.

Publication type:

Article

Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417

By:

Sitges, Marta;
Boluda, Blanca;
Garrido, Ana;
Morgades, Mireia;
Granada, Isabel;
Barragan, Eva;
Arnan, Montserrat;
Serrano, Josefina;
Tormo, Mar;
Miguel Bergua, Juan;
Colorado, Mercedes;
Salamero, Olga;
Esteve, Jordi;
Benavente, Celina;
Pérez‐Encinas, Manuel;
Coll, Rosa;
Martí‐Tutusaus, Josep‐Maria;
Brunet, Salut;
Sierra, Jorge;
Ángel Sanz, Miguel

Publication type:

Article

Monocenter study on epidemiology, outcomes, and risk factors of infections in recipients of 166 allogeneic stem cell transplantations during 1 year.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 126, doi. 10.1111/ejh.13416

By:

Samek, Markus;
Iversen, Katharina;
Belmar Campos, Cristina;
Berneking, Laura;
Langebrake, Claudia;
Wolschke, Christine;
Ayuk, Francis;
Kröger, Nicolaus;
Christopeit, Maximilian

Publication type:

Article

First‐line therapy with bendamustine/prednisone/bortezomib—A GMMG trial for non‐transplant eligible symptomatic multiple myeloma patients.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 116, doi. 10.1111/ejh.13409

By:

Knauf, Wolfgang;
Dingeldein, Gerrit;
Schlag, Rudolf;
Welslau, Manfred;
Moehler, Thomas;
Terzer, Tobias;
Walter, Sarah;
Habermehl, Christina;
Kunz, Christina;
Goldschmidt, Hartmut;
Raab, Marc‐Steffen

Publication type:

Article

Thioredoxin‐1 as a biological predictive marker for selecting diffuse large B‐cell lymphoma patients for etoposide‐containing treatment.

Published in:

European Journal of Haematology, 2020, v. 105, n. 2, p. 156, doi. 10.1111/ejh.13419

By:

Kari, Esa Jarkko Mikael;
Kuusisto, Milla Elvi Linnea;
Honkavaara, Päivi;
Hakalahti, Anna;
Haapasaari, Kirsi‐Maria;
Bloigu, Risto;
Karihtala, Peeter;
Teppo, Hanna‐Riikka;
Pirinen, Risto;
Turpeenniemi‐Hujanen, Taina;
Kuittinen, Outi

Publication type:

Article